How is the UroGen Pharma Ltd today?

The UroGen Pharma Ltd today is trading in the green, up by 3.31% at 5.00.

What is UroGen Pharma Ltd Annual Revenue?

UroGen Pharma Ltd Annual Revenue rose 9.29%, in the last year to $90.4 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is UroGen Pharma Ltd Annual Net Profit?

UroGen Pharma Ltd Annual Net Profit fell 24.09% in the last year to $126.87 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is UroGen Pharma Ltd Price to Earning Ratio?

UroGen Pharma Ltd Price to Earning Ratio is -1.67, which is negative.

What is UroGen Pharma Ltd Stock Price?

UroGen Pharma Ltd Stock Price fell 62.41% and underperformed its sector by 88.95% in the past year.

What is UroGen Pharma Ltd Quarterly Revenue?

UroGen Pharma Ltd Quarterly Revenue rose 7.84% YoY to $20.25 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is UroGen Pharma Ltd Quarterly Net profit?

UroGen Pharma Ltd Quarterly Net profit fell 35.8% YoY to $43.84 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is UroGen Pharma Ltd Mutual Fund Holding?

UroGen Pharma Ltd Mutual Fund Holding decreased by 1.21% in the last quarter to 14.77.

What is UroGen Pharma Ltd Promoter Share Holding?

UroGen Pharma Ltd Promoter Share Holding stayed the same in the most recent quarter at 4.33%.

What is UroGen Pharma Ltd Interest Coverage Ratio?

UroGen Pharma Ltd Interest Coverage Ratio is -8.91, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is UroGen Pharma Ltd Institutional Holding?

UroGen Pharma Ltd Institutional Holding increased by 60.81% in the last quarter to 75.58.

UroGen Pharma Ltd XNAS: URGN

UroGen Pharma Ltd Live Share Price Today, Share Analysis and Chart

Name: UroGen Pharma Ltd: Is Infosys Ltd. worth buying?
Item: UroGen Pharma Ltd
Rating: 0.65233325
Author: Trendlyne DVM scores

about

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing...

5.00 0.16 (3.31%)

75.85% Fall from 52W High

3.9M XNAS Volume

XNAS 03 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

11.8 / 100

Technically Bearish

14.3 / 100

24

1Yr Price target upside is 380%

7 analysts

UroGen Pharma Ltd Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

UroGen Pharma Ltd FAQ

How is UroGen Pharma Ltd today?

UroGen Pharma Ltd today is trading in the green, and is up by 3.31% at 5.00.

How has UroGen Pharma Ltd performed historically?

UroGen Pharma Ltd is currently trading up 3.31% on an intraday basis. In the past week the stock rose 19.33%. stock has been down -47.15% in the past quarter and fell -62.41% in the past year. You can view this in the overview section.